Skip to main content
    O

    OnKure Therapeutics, Inc. (OKUR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.58
    -0.17 (-6.18%)

    Market Cap: $113.27M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    OnKure Therapeutics, Inc. (OKUR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    OnKure Therapeutics (OKUR) has a market cap of $113.27M. Its share count is up 268.99% from a year earlier. It holds $151.44M more cash than debt, 133.70% of its market cap.

    Total Valuation

    Market Cap$113.27M
    Latest price (Nov 17, 2026)$2.58

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.12% in the quarter ended Sep 30, 2026.

    Shares Outstanding49.93M
    Shares Change (YoY)+268.99%
    Shares Change (QoQ)+0.12%

    Valuation Ratios

    Forward P/S906.2x
    P/B Ratio0.8x

    Price Statistics

    The stock is down 17.57% over 52 weeks and trades 4.44% below its 50-day average.

    Beta (1Y)1.25
    52-Week Change-17.57%
    1-Month Change+14.67%
    3-Month Change-36.76%
    6-Month Change-21.82%
    Total Return (1Y)-17.57%
    Return vs SPY (1Y)-23.50%
    Max Drawdown (1Y)-60.15%
    Max Drawdown (3Y)-90.47%
    Sharpe Ratio (1Y)-0.18
    Correlation with SPY (1Y)0.24
    50-Day Average$2.70
    200-Day Average$3.61
    52-Week Range$2.01 to $5.38
    RSI (14 Days)45.7
    Average Volume (20 Days)409.07K

    Price chart

    Financial Position

    Current assets cover 18.84x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio18.84x
    Quick Ratio18.84x
    Debt / Equity0.00x
    Interest Coverage15.95x

    Returns and Efficiency

    Return on equity is -39.21% and return on assets is -37.02% over the last 12 months.

    Return on Equity (ROE)-39.21%
    Return on Assets (ROA)-37.02%
    ROA (5Y Average)-62.86%
    ROIC (5Y Average)-88.51%

    Scores

    OKUR has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$202.00K
    Operating Income-$65.99M
    Pretax Income-$61.85M
    Net Income-$61.85M
    Reported EPS (TTM)-$2.77

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.41% of the $167.08M in total assets.

    Cash and Equivalents$151.44M
    Total Debt$0
    Net Cash$151.44M
    Net Cash Per Share$3.03
    Working Capital$156.80M
    Shareholder Equity$157.74M
    Book Value Per Share$3.16
    Total Assets$167.08M
    Total Liabilities$9.34M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $49.00K of capital spending, operating cash flow left -$47.94M of free cash flow.

    Operating Cash Flow-$47.89M
    Capital Expenditures$49.00K
    Free Cash Flow-$47.94M
    FCF Per Share-$1.18
    Depreciation and Amortization$737.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    OKUR does not pay a dividend. Its free cash flow yield is -37.21%.

    FCF Yield-37.21%
    Buyback Yield-116.79%
    Shareholder Yield-116.79%

    Stock Splits

    The last split was a 1-for-10 reverse split on Oct 7, 2024.

    Last Split DateOct 7, 2024
    Split TypeReverse split
    Split Ratio1:10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OKUR

    What is OKUR's market cap?

    OnKure Therapeutics has a market cap of $113.27M.

    How many shares of OKUR are outstanding?

    OnKure Therapeutics has 49.93M shares outstanding. The count is up 268.99% from a year earlier.

    Does OKUR pay a dividend?

    No. OnKure Therapeutics does not pay a dividend.

    How much debt does OKUR have?

    OnKure Therapeutics has $0 of total debt and $151.44M of cash and equivalents, a net cash position of $151.44M.